Core Points - The company has approved the first unlock period for the reserved grant of restricted stock, allowing 11 eligible incentive recipients to unlock 500,000 shares [2][14][21] - The total share capital of the company is 771,634,398 shares, and the unlocked shares represent 0.0648% of the total share capital [2][21] - The unlock date for the restricted stock is set for December 28, 2023, with a commitment to a 12-month lock-up period, making the shares tradable on July 25, 2025 [19][21] Summary by Sections Incentive Plan Approval - The incentive plan was approved through various board meetings, with the first grant involving 123 recipients and a total of 21,620,000 shares [3][6] - The initial grant price was set at 2.59 CNY per share, later adjusted to 2.49 CNY per share [4][6] Reserved Grant Details - The reserved grant consists of 5,049,910 shares, with similar unlocking conditions as the initial grant [4] - The first unlock period for the reserved shares is set to follow the same schedule as the initial grant [4] Unlock Conditions - The board confirmed that the conditions for unlocking the first reserved grant have been met, allowing for the release of 500,000 shares to the eligible recipients [14][18] - The company will repurchase any shares that do not meet the unlock conditions due to employee departures or other disqualifying factors [18] Stock Structure Changes - Following the unlock, the total number of shares will be adjusted accordingly, with the company maintaining compliance with relevant regulations [22][24] - The board and supervisory committee have both approved the unlock conditions and the related stock repurchase actions [22][23]
证券代码：002688 证券简称：金河生物 公告编号：2025-066